Prevalence of antibodies to β2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: A single center study and literature review

Journal of Rheumatology

Volumn 27, Issue 12, 2000, Pages 2833-2837

  Bruce, I N ^a   Clark Soloninka, C A ^a   Spitzer, K A ^a   Gladman, D D ^a   Urowitz, M B ^a   Laskin, C A ^a  

^a NONE   (Canada)

Author keywords

Anti 2 glycoprotein I; Antiphospholipid syndrome; Recurrent pregnancy loss; Systemic lupus erythematosus; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; BIOLOGICAL MARKER; GLYCOPROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; RECURRENT ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; ADOLESCENT; COHORT ANALYSIS; IMMUNOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GLYCOPROTEINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 0033623634     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
2. Immunology of the antiphospholipid antibody syndrome
3. Anticardiolipin antibodies in systemic lupus erythematosus. Clinical and laboratory correlations
4. Risk of venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus
5. 2-glycoprotein 1 antibodies: Where are we now?
6. The 1982 revised criteria for the classification of systemic lupus erythematosus
7. Antiphospholipid syndrome
8. Primary antiphospholipid syndrome
9. 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus
10. 2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: Prevalence and diagnostic value for the antiphospholipid syndrome
11. 2-glycoprotein I dependent antiphospholipid antibodies
12. 2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: Clinical correlations in comparison with other antiphospholipid antibody tests
13. 2-glycoprotein I antibodies in patients with systemic lupus erythematosus: Relationship with antiphospholipid syndrome
14. 2-glycoprotein: A potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus
15. Antibodies to beta-2-glycoprotein I - A specific marker for the antiphospbolipid syndrome
16. 2-glycoprotein I antibodies: A useful marker for the antiphospholipid syndrome
17. 2-glycoprotein I, antiprothrombin antibodies and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis
18. 2-glycoprotein I in patients with antiphospholipid syndrome
19. 2-glycoprotein I antibodies in systemic lupus erythematosus
20. 2-glycoprotein I than with antiphospholipid antibodies
21. 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus
22. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with SLE